Key result
HIV infection and antiretroviral therapy are associated with QTc interval prolongation and lower heart rate variability, which predict lethal cardiac arrhythmias and inflammatory-immune dysfunction.
Why the study?
Does HIV infection or antiretroviral therapy affect QT interval length and heart rate variability in persons living with HIV?
Does HIV infection or antiretroviral therapy affect QT interval length and heart rate variability in persons living with HIV?
ECG assessment of QTc and heart rate variability provides clinically relevant information for managing cardiovascular risk in persons living with HIV.
Answers are grounded in this paper and cite their sources.
QTc prolongation warrants ECG monitoring in HIV patients on ART; leaves open prospective arrhythmia risk assessment by regimen.
PURPOSE OF REVIEW: The increasing prevalence of cardiovascular disease comorbidity in persons infected with the HIV has become a global concern. The electrocardiogram (ECG) is increasingly being utilized to provide clinically relevant information regarding cardiac arrhythmias and cardio-autonomic dysfunction. The purpose of this review is to summarize the latest research comparing QT and R-to-R interval length as a function of HIV+ status or antiretroviral therapy (ART) regimen. RECENT FINDINGS: Prolongation of the corrected QTc interval may be acquired in HIV+ ART-naive individuals, exacerbated by various classes of ART drugs, and is generally predictive of lethal cardiac arrhythmias, with effects observed from childhood to adulthood. Recent literature also suggests the trend of lower heart rate variability in HIV is indicative of cardiorespiratory and inflammatory-immune dysfunction. SUMMARY: These emergent studies support the clinical relevance of the ECG across the age and HIV disease spectrum. Furthermore, the reported findings have implications for the management of cardiovascular and chronic inflammatory disease comorbidity in persons living with HIV.
No takes yet. Share an insight, caveat, or question.
McIntosh et al. (2017) conducted a review in HIV/AIDS. HIV+ status or antiretroviral therapy (ART) regimen was evaluated on QT and R-to-R interval length. HIV infection and antiretroviral therapy are associated with QTc interval prolongation and lower heart rate variability, which predict lethal cardiac arrhythmias and inflammatory-immune dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: